Informa Life Sciences is part of the Knowledge and Networking Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.
Director, Research at Visterra, Inc.
Karthik Viswanathan, Ph.D., is a founding scientist and Director of Research at Visterra, Inc., a clinical-stage biopharmaceutical company. As a founding scientist, he helped establish the Hierotope™ platform at Visterra that has led to discovery and development of multiple therapeutics. He is an inventor of VIS410, an anti-influenza A antibody currently in phase II clinical trials and VIS513, a cross-serotype neutralizing antibody against dengue that is in pre-clinical development. Prior to Visterra, Dr. Viswanathan was postdoctoral researcher at MIT. Dr. Viswanathan received his B. Tech from Indian Institute of Technology and Ph.D. from Johns Hopkins University. Dr. Viswanathan is an inventor on over 20 patent and patent applications and has authored over 35 publications in top tiered journals including Science, Cell, New England journal of Medicine and Nature Biotechnology.